These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11739323)

  • 1. Implantable cardioverter defibrillator: a Volkswagon or a Rolls Royce: how much will you pay to save a life?
    Hallstrom A
    Circulation; 2001 Dec; 104(24):E148. PubMed ID: 11739323
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce: how much will we pay to save a life?
    Zipes DP
    Circulation; 2001 Mar; 103(10):1372-4. PubMed ID: 11245637
    [No Abstract]   [Full Text] [Related]  

  • 3. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 4. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to avoid inappropriate therapy.
    Israel CW
    Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.
    Almendral J; Josephson ME
    Circulation; 2007 Sep; 116(10):1204-12. PubMed ID: 17768304
    [No Abstract]   [Full Text] [Related]  

  • 9. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing.
    Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the implantable cardioverter defibrillator?
    Hlatky MA; Bigger T
    Lancet; 2001 Jun; 357(9271):1817-8. PubMed ID: 11410185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy for ambulatory ventricular tachycardia: are we using an elephant gun?
    Kadish AH
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):665-6. PubMed ID: 15175061
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implantable cardioverter-defibrillator. Current indications and controversies.
    Raj SR; Sheldon RS
    Minerva Cardioangiol; 2002 Aug; 50(4):273-90. PubMed ID: 12147959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction.
    Strohmer B
    Pacing Clin Electrophysiol; 2005 Jan; 28(1):76-7. PubMed ID: 15660811
    [No Abstract]   [Full Text] [Related]  

  • 16. Inappropriate sensing of pectoral myopotentials by an implantable cardioverter defibrillator system.
    Karanam S; John RM
    Pacing Clin Electrophysiol; 2004 May; 27(5):688-9. PubMed ID: 15125734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A technique to overcome high defibrillation thresholds for an implantable cardioverter defibrillator.
    Boos CJ; Bentall AJ; Marshall HJ
    Cardiol Young; 2009 Jun; 19(3):291. PubMed ID: 19224670
    [No Abstract]   [Full Text] [Related]  

  • 18. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.